Friday, July 31, 2026

K-Beauty Gets Presidential Spotlight, but K-Botox Faces 16-Year Regulatory Hurdle

K-beauty gains prominence in diplomacy as top executives join a presidential delegation to Brazil, targeting the growing Latin American market.

LG Energy Solution Shares Surge on Major U.S. Energy Storage Battery Supply Agreement

LG Energy Solution signs a $1.6 billion contract with DTE Energy for 6GWh of energy storage batteries, boosting its stock price.

U.S., South Korea, and UAE Unite in Groundbreaking Military Drill

The combined scientific combat training exercise involving the armed forces of South Korea, the USA, and the UAE was conducted.

Tag: metabolic diseases

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Salidroside from Korean Ginseng Can Combat Insulin Resistance and Prevent Diabetes

Research reveals salicin from tianma improves insulin resistance, aiding diabetes prevention and intestinal health restoration.

Metabolic Surgery for Obese Seniors: A Safe Solution for Diabetes and Hypertension?

A study shows metabolic obesity surgery is safe for patients over 55, improving diabetes and other metabolic diseases effectively.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

Celltrion Moves CT-G32 Into Final Preclinical Stage as Global Obesity Trial Preparation Accelerates

Celltrion advances CT-G32, a next-gen obesity treatment, targeting multiple pathways to enhance weight loss while preserving muscle mass.

Frequent Delivery Meals and Abdominal Obesity Emerging as Key Drivers of Early Hypertension Risk

Increased use of delivery apps and late-night eating habits are raising hypertension and metabolic disease risks among young adults.

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

New Obesity Drug Shows Big Promise — and It’s Not from Eli Lilly or Novo

Metsera leads emerging obesity treatments with promising drug MET-233i, showing significant weight loss in trials, amid rising competition.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.